Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP29115.RAhp_VoZYOXOkAIAtg__32oZqfEX4JVLbdPqvUeDzDO1M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP29115.RAhp_VoZYOXOkAIAtg__32oZqfEX4JVLbdPqvUeDzDO1M130_assertion type Assertion NP29115.RAhp_VoZYOXOkAIAtg__32oZqfEX4JVLbdPqvUeDzDO1M130_head.
- NP29115.RAhp_VoZYOXOkAIAtg__32oZqfEX4JVLbdPqvUeDzDO1M130_assertion description "[Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP29115.RAhp_VoZYOXOkAIAtg__32oZqfEX4JVLbdPqvUeDzDO1M130_provenance.
- NP29115.RAhp_VoZYOXOkAIAtg__32oZqfEX4JVLbdPqvUeDzDO1M130_assertion evidence source_evidence_curated NP29115.RAhp_VoZYOXOkAIAtg__32oZqfEX4JVLbdPqvUeDzDO1M130_provenance.
- NP29115.RAhp_VoZYOXOkAIAtg__32oZqfEX4JVLbdPqvUeDzDO1M130_assertion SIO_000772 15805193 NP29115.RAhp_VoZYOXOkAIAtg__32oZqfEX4JVLbdPqvUeDzDO1M130_provenance.
- NP29115.RAhp_VoZYOXOkAIAtg__32oZqfEX4JVLbdPqvUeDzDO1M130_assertion wasDerivedFrom ctd_human-20150221 NP29115.RAhp_VoZYOXOkAIAtg__32oZqfEX4JVLbdPqvUeDzDO1M130_provenance.
- NP29115.RAhp_VoZYOXOkAIAtg__32oZqfEX4JVLbdPqvUeDzDO1M130_assertion wasGeneratedBy ECO_0000218 NP29115.RAhp_VoZYOXOkAIAtg__32oZqfEX4JVLbdPqvUeDzDO1M130_provenance.